Pershing Square Ups Stake In Valeant Pharmaceuticals (VRX)
Pershing Square acquires 2,144,618 shares of Valeant Pharmaceuticals (VRX) from 1-Oct-15 to 23-Nov-15
Total cost: $240,933,692
Pershing Square sells strangles to fund purchases of OTM calls;...
U.S. Capital Markets Review: Stocks Outpace Treasuries, Commodities
October was an eventful month as stock markets rebounded from their September selloff, oil prices stabilized somewhat, and the employment picture in the U.S....
Amazon (AMZN) Continues To Crush Traditional Retail
Here are a couple of good examples of how changes in demographics and consumer trends can affect markets.
We'll look at how Consumer banking and...
Investing In Drones: The Space Is Green Yet Uncertain
U.S. lawmakers are in a rush to regulate drones. Odds are pretty good that regulations will be unduly harsh at first. A heavy-up on rules...
Chart Spotlight: Is Copper Ready To Rally?
With the entire commodity space taking another nose dive, a specialty pattern indicator that I have been focusing on just popped up on my...
The Canaries Are Quiet: All Eyes On The Federal Reserve
The Canaries Are Quiet
In the late summer months of 2015 the Federal Reserve were actively discussing the possibility of raising the Federal Funds rate...
Gold Bulls Let Down Again In Precious Metals Latest Slide
For the last 2 or 3 years, Gold bulls have gotten their hopes up, only to be let down time and time again. In short,...
Apple Leaves A Bumbling Wall Street In The Stone Age
What happened after Apple's earnings serves as a stark reminder that for far too long the loudest voices have been heard and the knowledge...
Are Chinese Central Bank Actions Contradicting Economic Data?
In our latest article, “China Growth – Miracle or Mirage” published October 20, 2015, we questioned whether China’s perfectly forecasted and uniquely steady economic...
China Growth Story: Is It A Miracle Or Mirage?
“Pay no attention to the man behind the curtain!” – L. Frank Baum (The Wizard of Oz)
Once again, the release of China’s GDP on...
